NCT02463877View on ClinicalTrials.gov

A Minimally-invasive Approach to Cytoreduction and HIPEC for Peritoneal Surface Malignancy

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Cancer
Interventions
PROCEDURE

Minimally-Invasive Procedure

Laparoscopy

Trial Locations (1)

92093

UCSD Moores Cancer Center, La Jolla

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT02463877 - A Minimally-invasive Approach to Cytoreduction and HIPEC for Peritoneal Surface Malignancy | Biotech Hunter | Biotech Hunter